Estudo de coorte retrospectiva | Riscos de anafilaxia com formulações intravenosas de ferro.
31 Mar, 2022 | 13:19hRisks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University
Comentário: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay